Protagenic Therapeutics I...

0.00
-0.01 (-100.00%)
At close: Apr 17, 2025, 9:54 AM

Protagenic Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
-5.53M -5M -3.56M -4.52M -2.55M -1.75M -2.56M -2.26M -2.28M
50.29K 28.22K 30.00 427.14K 286.00 339.00 347.00 148.00 534.00
923.14K 666.83K 864.68K 1.52M 1.65M 797.76K 1.13M 888.28K 546.13K
467.54K -87.09K 631.73K -480.51K -361.43K 602.66K 11.14K -34.13K -54.19K
-132.14K 716.09K 156.85K 345.95K 154.9K 110.91K 246.19K 99.78K 150K
n/a n/a n/a -427.14K -248.55K -348.29K n/a -91.8K 440.78K
467.54K -114.41K 540.13K -140.39K -361.43K 702.2K 109.73K -16.87K -1.94K
-4.22M -3.7M -1.99M -2.8M -1.35M -487.99K -1.07M -1.38M -1.14M
n/a -149.78K -1.8K n/a n/a n/a n/a n/a n/a
n/a n/a 46.05K n/a n/a n/a n/a n/a n/a
-297.12K -2.76M -34.12K -10.4M n/a n/a -2.74M -3.43M n/a
3.05M 7.69M 1.63M 485.95K n/a 250K 3.79M 2.15M n/a
51.73K n/a -46.05K -9.91K n/a 250.00 1.05K -1.29K n/a
2.8M 4.78M 1.6M -9.91M n/a 250K 1.05M -1.29M n/a
n/a n/a n/a n/a 1.33M 670K n/a n/a 19K
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
1.96M n/a n/a 869.63K -104.09K n/a n/a n/a 4.26M
1.96M n/a n/a 12.58M 1.22M 670K n/a n/a 4.28M
550.58K 1.07M -325.98K -129.92K -127.53K 436.14K -37.2K -2.7M 3.1M
-4.22M -3.85M -2M -2.8M -1.35M -487.99K -1.07M -1.38M -1.14M